收费全文 | 95449篇 |
免费 | 8595篇 |
国内免费 | 4045篇 |
耳鼻咽喉 | 280篇 |
儿科学 | 1793篇 |
妇产科学 | 498篇 |
基础医学 | 7313篇 |
口腔科学 | 541篇 |
临床医学 | 11674篇 |
内科学 | 10632篇 |
皮肤病学 | 279篇 |
神经病学 | 6168篇 |
特种医学 | 5188篇 |
外国民族医学 | 74篇 |
外科学 | 14217篇 |
综合类 | 18081篇 |
现状与发展 | 8篇 |
一般理论 | 1篇 |
预防医学 | 4583篇 |
眼科学 | 764篇 |
药学 | 8329篇 |
75篇 | |
中国医学 | 4693篇 |
肿瘤学 | 12898篇 |
2025年 | 23篇 |
2024年 | 1428篇 |
2023年 | 2271篇 |
2022年 | 3438篇 |
2021年 | 4746篇 |
2020年 | 4370篇 |
2019年 | 3623篇 |
2018年 | 3377篇 |
2017年 | 3834篇 |
2016年 | 3957篇 |
2015年 | 3914篇 |
2014年 | 6291篇 |
2013年 | 6915篇 |
2012年 | 5678篇 |
2011年 | 6197篇 |
2010年 | 5146篇 |
2009年 | 4728篇 |
2008年 | 4668篇 |
2007年 | 4759篇 |
2006年 | 4440篇 |
2005年 | 3838篇 |
2004年 | 3029篇 |
2003年 | 2684篇 |
2002年 | 2203篇 |
2001年 | 1969篇 |
2000年 | 1587篇 |
1999年 | 1268篇 |
1998年 | 1105篇 |
1997年 | 1057篇 |
1996年 | 874篇 |
1995年 | 694篇 |
1994年 | 595篇 |
1993年 | 468篇 |
1992年 | 463篇 |
1991年 | 353篇 |
1990年 | 316篇 |
1989年 | 262篇 |
1988年 | 218篇 |
1987年 | 197篇 |
1986年 | 187篇 |
1985年 | 185篇 |
1984年 | 137篇 |
1983年 | 88篇 |
1982年 | 99篇 |
1981年 | 99篇 |
1980年 | 90篇 |
1979年 | 68篇 |
1978年 | 32篇 |
1977年 | 38篇 |
1976年 | 27篇 |
Aims
Concomitant chemoradiation is the standard of care in patients with inoperable non-small cell lung cancer. The purpose of this study was to analyse the survival outcome and toxicity data of using hypofractionated chemoradiation.Materials and methods
One hundred patients were treated from June 2011 to November 2016. Treatment consisted of 55 Gy in 20 daily fractions concurrently with split-dose cisplatin vinorelbine chemotherapy over 4 weeks followed by two cycles of cisplatin vinorelbine only. Survival was estimated using Kaplan–Meier and Cox regression was carried out for known prognostic factors. A systematic search of literature was conducted using Medline, Embase and Cochrane databases and relevant references included.Results
In total, 97% of patients completed radiotherapy and 73% of patients completed all four cycles of chemotherapy. One patient died of a cardiac event during consolidative chemotherapy. There were two cases of grade 4 toxicities (one sepsis, one renal impairment). Grade 3 toxicities included nausea/vomiting (17%), oesophagitis (15%), infection with neutropenia (12%) and pneumonitis (4%). Clinical benefit was seen in 86%. Two-year progression-free survival and overall survival rates were 49% and 58%, respectively. The median progression-free survival and overall survival were 23.4 and 43.4 months, respectively. The only significant prognostic factor was the number of chemotherapy cycles received (P = 0.02). The systematic review identified 13 relevant studies; a variety of regimens were assessed with variable reporting of outcomes and toxicity but with overall an improvement in survival over time.Conclusion
Our experience compared with the original phase II trial showed improved treatment completion rates and survival with acceptable morbidity. With appropriate patient selection this regimen is an effective treatment option for locally advanced non-small cell lung cancer. This study helps to benchmark efficacy and toxicity rates while considering the addition of new agents to hypofractionated concurrent chemoradiotherapy. The agreement of a standard regimen for assessment in future trials would be beneficial. 相似文献Design: Retrospective data analysis utilizing a local acute trauma registry for initial hospitalization and merged with the Dallas-Fort Worth Hospital Council registry to obtain subsequent health care utilization in the first post-injury year.
Setting: Dallas, TX, USA.
Participants: Six hundred and sixty four patients were admitted with an acute traumatic SCI from January 2003 through June 2014 to a Level I trauma center. Fifty five patients that expired during initial hospitalization and 18 patients with unspecified SCI (defined by ICD-9 with no etiology or level of injury specified) were not included in the analysis, leaving a final sample of 591.
Outcome Measures: Data included demographic and clinical characteristics, charges, and healthcare utilization.
Results: Mean age was 46.1?years (±18.9?years), the majority of patients were male (74%), and Caucasian (58%). Of the 591 patients, 345 (58%) had additional inpatient or emergency healthcare utilization accounting for 769 additional visits (median of 3 visits per person). Of the 769 encounters, 534 (69%) were inpatient and 235 (31%) were emergency visits not resulting in an admission. The most prevalent ICD-9 codes listed were pressure ulcer, neurogenic bowel, neurogenic bladder, urinary tract infection, fluid electrolyte imbalance, hypertension, and tobacco use.
Conclusion: Individuals with SCI experience high levels of healthcare utilization which are costly and may be preventable. Increasing our understanding of the prevalence and causes for healthcare utilization after acute SCI is important to target preventive strategies. 相似文献
- Download : Download high-res image (205KB)
- Download : Download full-size image